| Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy (NCT03144583) | Sara V. Latorre | 2017-06-15 |
| Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions (NCT03452306) | Geropharm | 2017-06-15 |
| Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer (NCT03180437) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Liver Cancer (NCT03183219) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants (NCT03182504) | Hoffmann-La Roche | 2017-06-15 |
| EGFR CART Cells for Patients With Metastatic Colorectal Cancer (NCT03152435) | Shenzhen Second People's Hospital | 2017-06-15 |
| Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects (NCT03189589) | GlaxoSmithKline | 2017-06-15 |
| Study of REGN3500 and Dupilumab in Patients With Asthma (NCT03112577) | Regeneron Pharmaceuticals | 2017-06-15 |
| Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B (NCT03109730) | Assembly Biosciences | 2017-06-15 |
| Airway Alkalinization and Nasal Colonization (NCT03078088) | Lakshmi Durairaj | 2017-06-15 |
| A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread (NCT03098550) | Bristol-Myers Squibb | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Breast Cancer (NCT03183206) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL) (NCT03135262) | Hoffmann-La Roche | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Lung Cancer (NCT03183232) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia (NCT03150771) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-06-14 |
| BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML) (NCT03127735) | Bayer | 2017-06-14 |
| Study of Copanlisib in Hepatic or Renal Impairment (NCT03172884) | Bayer | 2017-06-14 |
| SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers (NCT03138408) | AbbVie | 2017-06-14 |
| Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer (NCT02846792) | University of Washington | 2017-06-14 |
| Gene Therapy for Haemophilia A. (NCT03001830) | University College, London | 2017-06-14 |
| A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects (NCT03209648) | Debiopharm International SA | 2017-06-14 |
| A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers (NCT03207425) | Enanta Pharmaceuticals, Inc | 2017-06-14 |
| Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM (NCT03213002) | Northwell Health | 2017-06-13 |
| A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (NCT03137927) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-06-13 |
| Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome (NCT03173937) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-13 |
| This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment. (NCT03156114) | Boehringer Ingelheim | 2017-06-13 |
| Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging (NCT03069989) | GlaxoSmithKline | 2017-06-13 |
| Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP (NCT03196947) | Allarity Therapeutics | 2017-06-13 |
| Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient (NCT03294798) | Tianjin SinoBiotech Ltd. | 2017-06-13 |
| Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses (NCT03928366) | Parc de Salut Mar | 2017-06-13 |
| A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors (NCT03125746) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2017-06-12 |
| Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis (NCT03236792) | Icahn School of Medicine at Mount Sinai | 2017-06-12 |
| Oral Fecal Transplant in Cirrhosis (NCT03152188) | Virginia Commonwealth University | 2017-06-12 |
| Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus (NCT03103022) | University of Florida | 2017-06-12 |
| A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer (NCT05913115) | Amgen | 2017-06-12 |
| RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome (NCT02991807) | Boston Children's Hospital | 2017-06-12 |
| Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal (NCT03028857) | University of Colorado, Denver | 2017-06-12 |
| A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects (NCT03174548) | Sanofi | 2017-06-12 |
| Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma (NCT03172754) | Fox Chase Cancer Center | 2017-06-12 |
| Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma (NCT02774421) | University of Colorado, Denver | 2017-06-12 |
| Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer (NCT03056833) | Ronald Buckanovich | 2017-06-10 |
| The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers (NCT03247140) | Jeil Pharmaceutical Co., Ltd. | 2017-06-10 |
| A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects (NCT03162900) | Pfizer | 2017-06-09 |
| Anesthetics to Prevent Lung Injury in Cardiac Surgery (NCT02918877) | Beth Israel Deaconess Medical Center | 2017-06-09 |
| Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer (NCT03081494) | Novartis Pharmaceuticals | 2017-06-09 |
| Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects (NCT03282838) | Dr. Reddy's Laboratories Limited | 2017-06-09 |
| A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (NCT03052205) | Idera Pharmaceuticals, Inc. | 2017-06-09 |
| Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors (NCT03138889) | Nektar Therapeutics | 2017-06-09 |
| A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors (NCT03192345) | Sanofi | 2017-06-09 |
| A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) (NCT02978339) | John E. Eaton | 2017-06-09 |
| A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects (NCT03204474) | UCB Biopharma S.P.R.L. | 2017-06-08 |
| Characterization of Epilepsy Patients BEEP 2b (NCT02707965) | Food and Drug Administration (FDA) | 2017-06-08 |
| Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation) (NCT02425748) | Fuda Cancer Hospital, Guangzhou | 2017-06-08 |
| PP100-01 (Calmangafodipir) for Overdose of Paracetamol (NCT03177395) | Egetis Therapeutics | 2017-06-08 |
| A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression (NCT02891603) | H. Lee Moffitt Cancer Center and Research Institute | 2017-06-08 |
| CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma (NCT03029338) | Institute of Hematology & Blood Diseases Hospital, China | 2017-06-08 |
| A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126. (NCT03196804) | LG Chem | 2017-06-07 |
| Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure (NCT02808208) | Mayo Clinic | 2017-06-07 |
| This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated (NCT03159455) | Boehringer Ingelheim | 2017-06-07 |
| Thirdhand Smoke Contamination in a Neonatal Intensive Care Unit (NICU) (NCT04155697) | The University of Texas Health Science Center, Houston | 2017-06-07 |
| Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer (NCT03177460) | M.D. Anderson Cancer Center | 2017-06-07 |
| CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor (NCT03179007) | Shanghai Cell Therapy Research Institute | 2017-06-07 |
| A Systems Biology Approach to Malaria Immunity (NCT03014258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-07 |
| IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults (NCT03092791) | Takeda | 2017-06-07 |
| CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor (NCT03182816) | Shanghai Cell Therapy Research Institute | 2017-06-07 |
| CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor (NCT03182803) | Shanghai Cell Therapy Research Institute | 2017-06-07 |
| hCT-MSCs for Children With Autism Spectrum Disorder (ASD) (NCT03099239) | Joanne Kurtzberg, MD | 2017-06-06 |
| SynRinse Irrigation Pilot (SIP) Trial (NCT03154541) | University of Washington | 2017-06-06 |
| A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes (NCT03180710) | Adocia | 2017-06-06 |
| PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma (NCT03139331) | University of California, San Francisco | 2017-06-06 |
| LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma (NCT03101254) | Dana-Farber Cancer Institute | 2017-06-06 |
| AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy (NCT03092635) | Medical University of South Carolina | 2017-06-06 |
| 480 Biomedical Sinus Drug Depot (NCT02967731) | Lyra Therapeutics | 2017-06-06 |
| Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects (NCT03149848) | ViiV Healthcare | 2017-06-06 |
| A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM (NCT03176524) | Adocia | 2017-06-06 |
| Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its Metabolites (NCT03376841) | Allergan | 2017-06-06 |
| Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects. (NCT03172208) | Ablynx, a Sanofi company | 2017-06-05 |
| Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI (NCT03153319) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2017-06-05 |
| Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma (NCT03015922) | University of Leeds | 2017-06-05 |
| Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps (NCT03102190) | Benjamin Bleier | 2017-06-05 |
| Dose Escalation PfSPZ-CVac (NCT03083847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-05 |
| Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects (NCT03097341) | Aronora, Inc. | 2017-06-05 |
| A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma (NCT03003039) | Nanjing Yoko Biomedical Co., Ltd. | 2017-06-05 |
| Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction (NCT03767036) | Grünenthal GmbH | 2017-06-05 |
| A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy Participants (NCT03161405) | Millennium Pharmaceuticals, Inc. | 2017-06-05 |
| Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease (NCT03299413) | Hanan Jafar | 2017-06-05 |
| Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection (NCT02778204) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-05 |
| Safety and Immunogenicity of BBV121 (NCT04478656) | Bharat Biotech International Limited | 2017-06-03 |
| A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease (NCT03165071) | Idorsia Pharmaceuticals Ltd. | 2017-06-03 |
| Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients (NCT03186677) | ISU Abxis Co., Ltd. | 2017-06-03 |
| A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) (NCT03571308) | University Hospital Southampton NHS Foundation Trust | 2017-06-02 |
| APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma (NCT02706353) | M.D. Anderson Cancer Center | 2017-06-02 |
| Safety and Activity of Digoxin With Decitabine in Adult AML and MDS (NCT03113071) | Fox Chase Cancer Center | 2017-06-02 |
| Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty (NCT03234374) | Innocoll | 2017-06-02 |
| Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers (NCT03129347) | National Institute on Drug Abuse (NIDA) | 2017-06-01 |
| Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT03155191) | Takara Bio Inc. | 2017-06-01 |
| A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients (NCT03133247) | Atridia Pty Ltd. | 2017-06-01 |
| RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP (NCT03186482) | St. Stephens Clinical Research | 2017-06-01 |
| Pharmacological Modulation of Belief Salience (NCT03754062) | King's College London | 2017-06-01 |
| Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) (NCT03084380) | Xinqiao Hospital of Chongqing | 2017-06-01 |